Elite Diagnostic Income Statement

Financials in millions JMD. Fiscal year is July - June.

Millions JMD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	868.26	853.82	821.28	755.33	624.22	506.91
Revenue Growth (YoY)	4.87%	3.96%	8.73%	21.00%	23.14%	15.26%
Cost of Revenue	261.01	269.69	278.13	277.27	223.58	200.5
Gross Profit	607.24	584.14	543.16	478.06	400.64	306.4
Selling, General & Admin	340.23	342.65	311.39	276.9	210.66	174.77
Operating Expenses	512.7	512.76	446.61	413.35	318.19	276.83
Operating Income	94.54	71.38	96.54	64.71	82.45	29.58
Interest Expense	-28.82	-28.24	-48.64	-32.67	-27.33	-21.02
Interest & Investment Income	0.13	0.13	0.09	0.1	0.01	0.09
Currency Exchange Gain (Loss)	3.3	2.62	-3.32	-4.56	-6.47	-6.72
Other Non Operating Income (Expenses)	-10.29	-10.9	-14.15	-14.2	-	-
EBT Excluding Unusual Items	58.87	34.99	30.53	13.39	48.66	1.93
Asset Writedown	1.93	1.93	-1.18	-	-	-
Pretax Income	60.81	36.92	29.35	13.39	48.66	1.93
Income Tax Expense	5.24	4.9	3.19	0.04	-	-
Net Income	55.56	32.02	26.16	13.35	48.66	1.93
Net Income to Common	55.56	32.02	26.16	13.35	48.66	1.93
Net Income Growth	175.14%	22.44%	95.90%	-72.56%	2422.31%	-77.44%
Shares Outstanding (Basic)	353	353	353	353	353	353
Shares Outstanding (Diluted)	353	353	353	353	353	353
EPS (Basic)	0.16	0.09	0.07	0.04	0.14	0.01
EPS (Diluted)	0.16	0.09	0.07	0.04	0.14	0.01
EPS Growth	175.14%	22.44%	95.91%	-72.56%	2422.72%	-77.45%
Free Cash Flow	163.09	167.95	92.29	-25.87	-127.87	38.8
Free Cash Flow Per Share	0.46	0.47	0.26	-0.07	-0.36	0.11
Dividend Per Share	0.010	0.010	-	-	0.020	0.090
Dividend Growth	-	-	-	-	-77.78%	-
Gross Margin	69.94%	68.41%	66.14%	63.29%	64.18%	60.45%
Operating Margin	10.89%	8.36%	11.76%	8.57%	13.21%	5.83%
Profit Margin	6.40%	3.75%	3.19%	1.77%	7.80%	0.38%
Free Cash Flow Margin	18.78%	19.67%	11.24%	-3.43%	-20.48%	7.65%
EBITDA	232	206.47	199.83	173.05	177.25	116.11
EBITDA Margin	26.72%	24.18%	24.33%	22.91%	28.40%	22.91%
D&A For EBITDA	137.46	135.1	103.29	108.33	94.8	86.53
EBIT	94.54	71.38	96.54	64.71	82.45	29.58
EBIT Margin	10.89%	8.36%	11.76%	8.57%	13.21%	5.83%
Effective Tax Rate	8.62%	13.27%	10.88%	0.26%	-	-
Advertising Expenses	-	3.42	5.23	9.61	5.9	4.06

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.